PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease: Trends in Pharmacological Sciences
Frontiers | Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases | Pharmacology
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases | Pharmacology
Action of PDE4 inhibitors can prolong or enhance effects of cAMP and... | Download Scientific Diagram
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders - ScienceDirect
Combined-inhibition-of-phosphodiesterase-PDE3-and-PDE4-inhibitors-has-additive-and – Dr. Mahler
Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate: Molecular Therapy
The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells - ScienceDirect
Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis - ScienceDirect
PDE4 Inhibitors, Boehringer Ingelheim Pharmaceuticals | New Drug Approvals
Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity | Reumatología Clínica
Treating brain tumors with PDE4 inhibitors: Trends in Pharmacological Sciences
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
Schematic representation of how Phosphodiesterase 4 (PDE4) inhibitors,... | Download Scientific Diagram
R)-(-)-Rolipram, Selective PDE4 inhibitor (CAS 85416-75-7) (ab120031) | Abcam
Rolipram is a Selective Phosphodiesterases PDE4 Inhibitor - Immune System Research
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition - Guttman‐Yassky - 2019 - Experimental Dermatology - Wiley Online Library
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases | Pharmacology
PDE4 inhibition reduces the release of a variety of pro-inflammatory... | Download Scientific Diagram
DALIRESP® (roflumilast) Mechanism of Action | For HCPs
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases | Semantic Scholar
Phosphodiesterase inhibitors - Knowledge @ AMBOSS
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook | Semantic Scholar
Frontiers | Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease | Pharmacology
PLOS ONE: Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis
